XIST
KLNMA
Market cap2.58bUSD
Nov 12, Last price
12.12TRY
Name
Turkiye Kalkinma Bankasi AS
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Türkiye Kalkinma ve Yatirim Bankasi A.S. operates as a specialized financial institution in Turkey, providing both development and investment banking services. Its operations are organized into corporate banking and investment banking divisions. The bank offers a broad spectrum of financing, encompassing corporate loans, investment loans, and project funding for key sectors such as industry, renewable energy, energy efficiency, tourism, education, and health. Its lending facilities also include Turkish Lira and foreign exchange business loans, letters of credit, and guarantees, alongside its wholesale banking activities. The institution's services extend to money and capital markets, involving repurchase and reverse repurchase agreements, the trade of bills and bonds, and derivative products. It delivers comprehensive advisory services covering capital markets, including public offerings, the issuance of debt instruments, Sharia-compliant capital market products, structured finance arrangements, and asset-backed securities. Furthermore, the bank provides consultation on corporate restructuring, financial feasibility studies, capital structuring, and mergers and acquisitions. It also features sustainable finance solutions and a variety of other financial services. The bank additionally facilitates the buying and selling of its proprietary investment funds, government bonds, and treasury bills. Established in 1975, the company initially operated under the name Devlet Sanayi ve Isçi Yatirim Bankasi A.S. before adopting its current designation, Türkiye Kalkinma ve Yatirim Bankasi A.S., in July 1988. Its headquarters are located in Ümraniye, Turkey.
Valuation
Title TRY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||